The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization

被引:245
|
作者
Prota, Andrea E. [1 ]
Danel, Franck [2 ]
Bachmann, Felix [2 ]
Bargsten, Katja [1 ]
Buey, Ruben M. [1 ]
Pohlmann, Jens [2 ]
Reinelt, Stefan [2 ]
Lane, Heidi [2 ]
Steinmetz, Michel O. [1 ]
机构
[1] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland
[2] Basilea Pharmaceut Int Ltd, CH-4058 Basel, Switzerland
关键词
microtubule-targeting drugs; tubulin; X-ray crystallography; biochemistry; molecular mechanism; ALPHA-BETA-TUBULIN; STRUCTURAL BASIS; MOLECULAR-MECHANISM; AGENT; FLUORESCENCE; VINBLASTINE; RESISTANCE; DYNAMICS; INSIGHT; COMPLEX;
D O I
10.1016/j.jmb.2014.02.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microtubule-targeting agents are widely used for the treatment of cancer and as tool compounds to study the microtubule cytoskeleton. BAL27862 is a novel microtubule-destabilizing drug that is currently undergoing phase I clinical evaluation as the prodrug BAL101553. The drug is a potent inhibitor of tumor cell growth and shows a promising activity profile in a panel of human cancer models resistant to clinically relevant microtubule-targeting agents. Here, we evaluated the molecular mechanism of the tubulin-BAL27862 interaction using a combination of cell biology, biochemistry and structural biology methods. Tubulin-binding assays revealed that BAL27862 potently inhibited tubulin assembly at 37 degrees C with an IC50 of 1.4 mu M and bound to unassembled tubulin with a stoichiometry of 1 mol/mol tubulin and a dissociation constant of 244 +/- 30 nM. BAL27862 bound to tubulin independently of vinblastine, without the formation of tubulin oligomers. The kinetics of BAL27862 binding to tubulin were distinct from those of colchicine, with evidence of competition between BAL27862 and colchicine for binding. Determination of the tubulin-BAL27862 structure by X-ray crystallography demonstrated that BAL27862 binds to the same site as colchicine at the intradimer interface. Comparison of crystal structures of tubulin-BAL27862 and tubulin-colchicine complexes shows that the binding mode of BAL27862 to tubulin is similar to that of colchicine. However, comparative analyses of the effects of BAL27862 and colchicine on the microtubule mitotic spindle and in tubulin protease-protection experiments suggest different outcomes of tubulin binding. Taken together, our data define BAL27862 as a potent, colchicine site-binding, microtubule-destabilizing agent with distinct effects on microtubule organization. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1848 / 1860
页数:13
相关论文
共 27 条
  • [21] Structure-activity relationship study anti. microtubule agents targeting the colchicine site on tubulin that circumvent drug resistance
    Gangjee, Aleem
    Xiang, Weiguo
    Mooberry, Susan L.
    Hamel, Ernest
    CANCER RESEARCH, 2013, 73 (08)
  • [22] A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity
    Du, Tingting
    Lin, Songwen
    Ji, Ming
    Xue, Nina
    Liu, Yichen
    Zhang, Zhihui
    Zhang, Kehui
    Zhang, Jingbo
    Zhang, Yan
    Wang, Qinghua
    Sheng, Li
    Li, Yan
    Lu, Duo
    Chen, Xiaoguang
    Xu, Heng
    CANCER LETTERS, 2020, 495 : 22 - 32
  • [23] A Combretastatin Analogue C12 Binds to Colchicine Site in Tubulin, Inhibits Spindle Microtubule Dynamics, Activates Mitotic Checkpoint and Induces Apoptosis in Cancer Cells
    Kumari, Anuradha
    Srivastava, Shalini
    Prassanawar, Shweta Shyam
    Sisodiya, Shailendra
    Guchhait, Sankar K.
    Panda, Dulal
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 415A - 415A
  • [24] MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo
    Chen, Chun-Han
    Li, Ya-Chi
    Chang, Li-Hsun
    Liou, Jing-Ping
    Pan, Shiow-Lin
    Teng, Che-Ming
    CANCER RESEARCH, 2013, 73 (08)
  • [25] N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity
    Keenan, Bryce
    Finol-Urdaneta, Rocio K.
    Hope, Ashleigh
    Bremner, John B.
    Kavallaris, Maria
    Lucena-Agell, Daniel
    Oliva, Maria Angela
    Diaz, Jose Fernando
    Vine, Kara L.
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [26] N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity
    Bryce Keenan
    Rocio K. Finol-Urdaneta
    Ashleigh Hope
    John B. Bremner
    Maria Kavallaris
    Daniel Lucena-Agell
    María Ángela Oliva
    Jose Fernando Díaz
    Kara L. Vine
    Cancer Cell International, 20
  • [27] NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site
    Das Mukherjee, Dipanwita
    Kumar, N. Maruthi
    Tantak, Mukund P.
    Datta, Satabdi
    Dastidar, Debabrata Ghosh
    Kumar, Dalip
    Chakrabarti, Gopal
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2020, 1867 (10):